Effect of Probiotic Formula DE111® on Immune System in Preschool Children

NCT ID: NCT04077034

Last Updated: 2019-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

102 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-02

Study Completion Date

2019-08-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Healthy preschool children will be recruited, gastrointestinal infection and respiratory infection symptoms will be followed during the 8-week treatment and 4-week follow-up period, to evaluate the effect of the used probiotic formula on immune system in comparison to the group using placebo.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immune System Support

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Probiotic DE111®

Group Type EXPERIMENTAL

Probiotic Formula Bacillus subtilis DE111®

Intervention Type DIETARY_SUPPLEMENT

Probiotic Formula Bacillus subtilis DE111®, 1 billion colony forming units (CFU) per day for 8 weeks

Control group

Placebo

Group Type PLACEBO_COMPARATOR

Placebo comparator

Intervention Type DIETARY_SUPPLEMENT

Placebo comparator, once a day for 8 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Probiotic Formula Bacillus subtilis DE111®

Probiotic Formula Bacillus subtilis DE111®, 1 billion colony forming units (CFU) per day for 8 weeks

Intervention Type DIETARY_SUPPLEMENT

Placebo comparator

Placebo comparator, once a day for 8 weeks

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* signed informed consent by at least one parent or legal guardian
* children aged 2 to 6 years
* attending or about to start attending day-care

Exclusion Criteria

* body weight at birth \<2500g
* gestational age \<37 weeks
* severe chronic illness
* regular use of medication
* immunodeficiency
* parent or legal guardian not able to understand and comply with requirements of the study
Minimum Eligible Age

2 Years

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vizera d.o.o.

INDUSTRY

Sponsor Role collaborator

University of Ljubljana

OTHER

Sponsor Role collaborator

Deerland Enzymes

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lilijana Kocijancic Besednjak, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Health Center Nova Gorica

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Health center Laško

Laško, , Slovenia

Site Status

Pediatrija Krebs

Maribor, , Slovenia

Site Status

Pediatrinja d.o.o.

Maribor, , Slovenia

Site Status

Zasebna otroska in solska ambulanta

Maribor, , Slovenia

Site Status

Health Center Nova Gorica

Šempeter pri Gorici, , Slovenia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Slovenia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IMMUNO-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Children Immune Functions
NCT01717534 COMPLETED NA
Children Immune Functions(2)
NCT01731392 COMPLETED NA